Denali Advisors LLC Moderna, Inc. Transaction History

Denali Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 21, 2023	BUY	$135.66 - $197.02 $81,396 - $118,212	600 Added 100.0%	1,200 $184,000
Q4 2022 Feb 09, 2023	SELL	$118.38 - $210.04 $59,190 - $105,020	-500 Reduced 45.45%	600 $107,000
Q3 2022 Oct 25, 2022	BUY	$118.07 - $194.18 $82,649 - $135,926	700 Added 175.0%	1,100 $130,000
Q2 2022 Jul 18, 2022	BUY	$117.13 - $176.59 $46,852 - $70,636	400 New	400 $57,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Denali Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Denali Advisors LLC with notifications on news.